Bill Snyder
-
Study reveals neurotransmitter glutamate’s molecular structure
Terunaga Nakagawa, with colleagues from Japan and Oxford University in England, has discovered the bridgelike molecular structure of a mysterious glutamate receptor. Read MoreAug 11, 2016
-
HIV treatment and TB risk
Tuberculosis (TB) remains an important public health problem, particularly among people infected with the human immunodeficiency virus (HIV). Read MoreAug 4, 2016
-
Possible overeating antidote
The 2C-subtype of the serotonin receptor (5HT2C), which binds the neurotransmitter serotonin, plays an important role in regulating food intake and metabolism. Read MoreAug 1, 2016
-
Award bolsters study of alcohol’s impact on the brain
Vanderbilt University researcher Danny Winder, Ph.D., has received a MERIT Award from the National Institute of Alcohol Abuse and Addiction (NIAAA), part of the National Institutes of Health, for his contributions to understanding how alcohol affects the brain. Read MoreJul 28, 2016
-
Opioids’ impact on women’s health explored at research symposium
Women may be at higher risk than men when it comes to overuse of opioid-containing painkillers, speakers warned at a research symposium at Vanderbilt University Medical Center earlier this month. Read MoreJul 28, 2016
-
Breast cancer: finding the smoking gun
A new method developed at Vanderbilt may help “inventory” all tumor-promoting genes. Read MoreJul 20, 2016
-
Diabetes drugs may ease addiction
Drugs that are being used clinically to treat obesity and diabetes may also have a role in treating drug abuse. Read MoreJul 18, 2016
-
Influx of major NIH grants fuels growth of research enterprise
During the past two weeks, researchers at Vanderbilt University and Vanderbilt University Medical Center (VUMC) have brought in a number of new research grants from the National Institutes of Health (NIH) that together achieve $137 million in new funding. The funding is a trans-institutional accomplishment of the Schools of Engineering and Medicine and the College of Arts and Science. Read MoreJul 14, 2016
-
Membrane fats impact drug transporter
New studies of a membrane transporter could explain antibiotic resistance – and lead to novel ways to combat it. Read MoreJul 14, 2016
-
VUMC chosen for leadership role in NIH Precision Medicine Initiative Cohort Program
Vanderbilt University Medical Center has been chosen by the National Institutes of Health to be a leader in a landmark study of genetic, environmental and lifestyle factors affecting the health of a million or more people. The NIH will provide $71.6 million over five years to VUMC, making this the largest research grant the Medical Center has ever received from any source. Read MoreJul 7, 2016
-
VUMC symposium to explore risks, impact of opioids
The risks of taking opioids during pregnancy or to manage chronic pain, and the impact this frequently prescribed class of pain relievers has on the adolescent brain will be discussed Wednesday, July 13, during a “bedside-to-bench” symposium at Vanderbilt University Medical Center. Read MoreJul 7, 2016
-
VUMC chosen for leadership role in NIH Precision Medicine Initiative Cohort Program
Vanderbilt University Medical Center (VUMC) has been chosen by the National Institutes of Health (NIH) to be the Data and Research Support Center for the Precision Medicine Initiative Cohort Program, a landmark study of genetic, environmental and lifestyle factors affecting the health of a million or more people, federal officials have announced. Read MoreJul 7, 2016
-
Vanderbilt establishes Recruitment Innovation Center to increase enrollment of minorities, women and older adults in clinical trials
Many clinical trials are stopped prematurely because they fail to recruit enough study participants. Vanderbilt University Medical Center has received a five-year, $14 million grant from the National Center for Advancing Translational Sciences at the National Institutes of Health to address this. Read MoreJul 5, 2016
-
New NIH-funded center to study inefficiencies in clinical trials
Researchers at Vanderbilt University Medical Center and Duke Clinical Research Institute have received a major federal grant to study how multisite clinical trials of new drugs and therapies in children and adults can be conducted more rapidly and efficiently. Read MoreJul 5, 2016
-
Superior scan for tumors
Imaging with a compound that binds to neuroendocrine cells is a safer and more effective way to detect rare neuroendocrine tumors. Read MoreJun 24, 2016
-
It takes two to tango: beta cell development
Defining the genes required for the function of insulin-producing beta cells is crucial for ongoing efforts to develop a cell-based therapy for diabetes. Read MoreJun 23, 2016
-
Goldenring recognized for research mentorship efforts
James Goldenring, M.D., Ph.D., co-director of the Epithelial Biology Center at Vanderbilt University Medical Center (VUMC), has received a Research Mentor Award from the American Gastroenterology Association Institute Council for “outstanding research mentorship.” Read MoreJun 23, 2016
-
Vanderbilt and Human Vaccines Project launch initial studies to decode the human immune system
Researchers at Vanderbilt University Medical Center this month began recruiting volunteers to participate in a clinical trial aimed at decoding the human “immunome,” the genetic underpinnings of the immune system. Read MoreJun 21, 2016
-
VUMC part of national effort to improve genomic science laws, regulations
Experts in medicine and the law at the University of Minnesota and Vanderbilt University Medical Center (VUMC) are leading a national effort to analyze and recommend improvements in genomic law. Read MoreJun 16, 2016
-
Hasty selected to participate in academic medicine program for women
Alyssa Hasty, Ph.D., a Vanderbilt obesity researcher, has been selected to participate in the 22nd class of the Hedwig van Ameringen Executive Leadership in Academic Medicine Program for Women. Read MoreJun 9, 2016